Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection

被引:246
作者
Knobler, H
Schihmanter, R
Zifroni, A
Fenakel, G
Schattner, A [1 ]
机构
[1] Kaplan Med Ctr, Dept Med, IL-76100 Rehovot, Israel
[2] Kaplan Med Ctr, Metab Unit, IL-76100 Rehovot, Israel
[3] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel
关键词
D O I
10.4065/75.4.355
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To investigate whether patients with chronic hepatitis C virus (HCV) infection without evidence of cirrhosis have an increased risk of diabetes mellitus (DM) and to evaluate possible risk factors for diabetes in this group. Patients and Methods: We conducted a case-control study of 45 consecutive eligible patients with HCV infection and no clinical, scintigraphic? or histological evidence of cirrhosis, and a control group of 90 subjects without liver disease matched by age, sex, and body mass index and similar in their origin distribution. Eighty-eight patients with chronic hepatitis B virus (HBV) infection with no evidence of cirrhosis were also evaluated. The diagnosis of diabetes was based on the 1997 American Diabetes Association criteria. Results: Fifteen patients (33%) with HCV infection were found to have type 2 diabetes compared with 5.6% in the control group without liver disease (P<.001) and 12% in the group with HBV infection (P=.004). Comparison of the patients with and without diabetes revealed that positive family history of diabetes, HCV 1b genotype, and a more severe liver histology were significantly associated with DM. Conclusions: Patients with chronic HCV infection have an increased prevalence of type 2 diabetes, and this prevalence is independent of cirrhosis. The pathogenesis is intriguing, appears to be unique to HCV, and requires further study.
引用
收藏
页码:355 / 359
页数:5
相关论文
共 25 条
[1]   EVIDENCE FOR A LINK BETWEEN HEPATITIS-C VIRUS-INFECTION AND DIABETES-MELLITUS IN A CIRRHOTIC POPULATION [J].
ALLISON, MED ;
WREGHITT, T ;
PALMER, CR ;
ALEXANDER, GJM .
JOURNAL OF HEPATOLOGY, 1994, 21 (06) :1135-1139
[2]   ALTERATIONS OF GLUCOSE-METABOLISM IN CHRONIC LIVER-DISEASE [J].
BLANCO, CD ;
GENTILE, S ;
MARMO, R ;
CARBONE, L ;
COLTORTI, M .
DIABETES RESEARCH AND CLINICAL PRACTICE, 1990, 8 (01) :29-36
[3]   Nutritional and metabolic effects of alcoholism: Their relationship with alcoholic liver disease [J].
Bunout, D .
NUTRITION, 1999, 15 (7-8) :583-589
[4]   Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C [J].
Chedin, P ;
CahenVarsaux, J ;
Boyer, N .
ANNALS OF INTERNAL MEDICINE, 1996, 125 (06) :521-521
[5]   Hepatitis C [J].
Di Bisceglie, AM .
LANCET, 1998, 351 (9099) :351-355
[6]  
Fraser GM, 1996, ISRAEL J MED SCI, V32, P526
[7]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[8]   HIGH PREVALENCE OF HEPATITIS-C INFECTION IN AFRO-CARIBBEAN PATIENTS WITH TYPE-2 DIABETES AND ABNORMAL LIVER-FUNCTION TESTS [J].
GRAY, H ;
WREGHITT, T ;
STRATTON, IM ;
ALEXANDER, GJM ;
TURNER, RC ;
ORAHILLY, S .
DIABETIC MEDICINE, 1995, 12 (03) :244-249
[9]  
Grimbert S, 1996, GASTROEN CLIN BIOL, V20, P544
[10]   HEPATITIS-C - A MULTIFACETED DISEASE - REVIEW OF EXTRAHEPATIC MANIFESTATIONS [J].
GUMBER, SC ;
CHOPRA, S .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (08) :615-620